2017 will place Medicare Advantage stakeholders at a critical crossroads in a post election environment. The landscape will be shaped by recent provider value based payment innovations; increased CMS oversight and initiatives including star ratings, increased competition; mega health plans seeking market share outside of exchange populations and hedging against antitrust uncertainties; as well as many other factors. In particular, implications are significant for provider sponsored and regional plans and provider networks.

The MA market contains many of the elements needed for business success, from changing demographics moving in its favor to market receptivity for the product category. In addition, the financial model needed for MA success is favorable as an increasing number of providers are accepting capitation or various reimbursement arrangements under a value-based model being promoted by CMS and others.

But the MA industry is one fraught with regulation, dependent on a single payer – CMS – operating on slim margins, reliant on provider cooperation, hostage to the introduction of costly new specialty drugs, and engulfed in consolidations that give mega brands a decided competitive advantage.

This session will position stakeholders for 2017 and beyond by providing a deeper understanding of the current Medicare environment; an examination of the intricacies of the challenges facing Medicare Advantage plans and networks - especially provider sponsored and regional plans and networks - as they seek to compete in an era of consolidation and revenue compression; and identify and discuss selected strategic opportunities to achieve success in serving Medicare Advantage members.

Please join us Thursday September 22nd, 2016 at 1 PM Eastern as Strategic Health Group's Hank Oswoski helps position stakeholders for the future that are involved with Medicare Advantage plans. Click here for detailed information and to register or call 209.577.4888.